Where can I buy organigram stock?
Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is OrganiGram's stock price today?
What are the price targets for organigram's shares?
9 equities research analysts have issued 1 year price targets for OrganiGram's shares. Their forecasts range from C$2.25 to C$5.00. On average, they anticipate OrganiGram's share price to reach C$3.48 in the next twelve months. This suggests a possible upside of 80.3% from the stock's current price.
What are analysts'forecasts for organigram's stock's price?
9 brokerages have issued 1-year price objectives for OrganiGram's stock. Their forecasts range from $2.25 to $5.30. On average, they expect OrganiGram's share price to reach $3.69 in the next year. This suggests a possible upside of 138.3% from the stock's current price.
How much does organigram make a year?
OrganiGram has a market capitalization of $464.77 million and generates $62.43 million in revenue each year. The company earns $-103.09 million in net income (profit) each year or ($0.30) on an earnings per share basis. How many employees does OrganiGram have?
Is OrganiGram a buy or sell?
OrganiGram has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.
Should I sell my OrganiGram stock?
Organigram Holdings(OGI-X) Rating A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
What is the outlook for OrganiGram?
OrganiGram Holdings Inc (NASDAQ:OGI) The 10 analysts offering 12-month price forecasts for OrganiGram Holdings Inc have a median target of 2.02, with a high estimate of 2.90 and a low estimate of 1.59. The median estimate represents a +119.95% increase from the last price of 0.92.
Does OrganiGram stock pay dividends?
ORGANIGRAM HOLDINGS (NASDAQ: OGI) does not pay a dividend.
Is OGI a good company?
PB vs Industry: OGI is good value based on its Price-To-Book Ratio (0.9x) compared to the CA Pharmaceuticals industry average (1.1x).
How do you buy OrganiGram holding stocks?
How to buy stocks in OrganiGramCompare stock trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Is OHI stock a buy or sell?
For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Should I buy or sell OrganiGram stock right now?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last twelve months. There are currently 3 hold ratings a...
What is OrganiGram's stock price forecast for 2022?
7 equities research analysts have issued twelve-month target prices for OrganiGram's shares. Their forecasts range from $2.25 to $5.30. On average,...
How has OrganiGram's stock performed in 2022?
OrganiGram's stock was trading at $1.75 at the start of the year. Since then, OGI stock has decreased by 40.0% and is now trading at $1.05. View t...
When is OrganiGram's next earnings date?
OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, July 12th 2022. View our earnings forecast for OrganiGram .
How were OrganiGram's earnings last quarter?
OrganiGram Holdings Inc. (NASDAQ:OGI) announced its quarterly earnings results on Tuesday, April, 12th. The company reported ($0.02) earnings per s...
Who are OrganiGram's key executives?
OrganiGram's management team includes the following people: Mr. Derrick W. West CPA , CPA, (CA), Chief Financial Officer (Age 55, Pay $241.72k)...
Who are some of OrganiGram's key competitors?
Some companies that are related to OrganiGram include BELLUS Health (BLUSF) , Madrigal Pharmaceuticals (MDGL) , Lyell Immunopharma (LYEL) , Cry...
What other stocks do shareholders of OrganiGram own?
Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB) , (CGC) ,...
What is OrganiGram's stock symbol?
OrganiGram trades on the NASDAQ under the ticker symbol "OGI."
Is OrganiGram stock a Buy, Sell or Hold?
OrganiGram stock has received a consensus rating of sell. The average rating score is and is based on 0 buy ratings, 0 hold ratings, and 1 sell rat...
What was the 52-week low for OrganiGram stock?
The low in the last 52 weeks of OrganiGram stock was 1.07. According to the current price, OrganiGram is 103.74% away from the 52-week low.
What was the 52-week high for OrganiGram stock?
The high in the last 52 weeks of OrganiGram stock was 3.52. According to the current price, OrganiGram is 31.58% away from the 52-week high.
What are analysts forecasts for OrganiGram stock?
The 1 analysts offering price forecasts for OrganiGram have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The m...
About OrganiGram
Headlines
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
OrganiGram (NASDAQ:OGI) Frequently Asked Questions
CGC: Canopy Growth vs. OrganiGram: Which Cannabis Stock Is a Better Buy? - StockNews.com
Organigram Reports Highest Quarterly Net Revenue Ever In Q1, Remains Among Top Canadian Cannabis LPs
9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last twelve months. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OrganiGram stock.
Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market
Cannabis company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced its results for the first quarter ended November 30, 2021.
Should I hold Organigram stock?
OrganiGram Holdings Inc (NASDAQ: OGI) (TSE: OGI) CEO Beena Goldenberg recently spoke with Benzinga to discuss the company's ongoing growth and Q2 success.
Is Organigram a hold?
The consensus among Wall Street analysts is that investors should "hold" OrganiGram stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OGI, but not buy additional shares or sell existing shares.
OGI Overview
Wall Street analysts have given OrganiGram a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OrganiGram wasn't one of them.
Zen Score
OrganiGram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis... read more
Due Diligence Checks
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OGI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Profit margin
OGI's profit margin has increased... subscribe to Premium to read more.
Assets to liabilities
OGI's cash and short-term investments... subscribe to Premium to read more.
Cash flow
OGI's short-term assets ($193.17M) exceed... subscribe to Premium to read more.
How to buy shares in OrganiGram
OGI's cash and short-term investments... subscribe to Premium to read more.
Buy OrganiGram shares from these brokerages
Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
Is it a good time to buy OrganiGram stock?
Compare special offers, low fees and a wide range of types of investments among top trading platforms.
OrganiGram share dividends
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Have OrganiGram's shares ever split?
We're not expecting OrganiGram to pay a dividend over the next 12 months.
OrganiGram share price volatility
OrganiGram's shares were split on a 67:1 basis on 27 January 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 67 shares. This wouldn't directly have changed the overall worth of your OrganiGram shares – just the quantity.
OrganiGram overview
Over the last 12 months, OrganiGram's shares have ranged in value from as little as $1.3 up to $4.68. A popular way to gauge a stock's volatility is its "beta".
Premium Research for OGI
Organigram Holdings Inc. , through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co.
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Historical and forecast chart of OrganiGram Holdings stock
Organigram Holdings Inc. is a licensed producer of cannabis and cannabis-derived products primarily in Canada, through a wholly owned subsidiary. Organigram Holdings Inc. is based in Moncton, Canada.
OrganiGram Holdings Daily Price Targets
The chart below shows the historical price of OrganiGram Holdings stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast.
OrganiGram Holdings forecast for this year
Forecast target price for 02-24-2022: $ 1.62. Positive dynamics for OrganiGram Holdings shares will prevail with possible volatility of 7.805%.